VAERS Explorer
Back to explore

Report #2879323

Received Dec 23, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
PR
Recovered
Not recovered
Vaccinated
Nov 30, 2025
Onset
Dec 1, 2025
Days to onset
1
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1UNK—

Symptoms (5)

ErythemaHeadacheMalaisePain in extremitySwelling

Symptom narrative

arm pain; Headache; general malaise; redness/ red area; mild swelling; This non-serious case was reported by a consumer and described the occurrence of pain in arm in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Concomitant products included pantoprazole, vitamins nos (Multivitamin), glutathione, probiotics nos, progesterone, estradiol and testosterone. On 30-NOV-2025, the patient received the 1st dose of Shingrix. On 01-DEC-2025, 1 days after receiving Shingrix, the patient experienced pain in arm (Verbatim: arm pain), headache (Verbatim: Headache), general malaise (Verbatim: general malaise), erythema (Verbatim: redness/ red area) and swelling (Verbatim: mild swelling). The outcome of the pain in arm, headache, general malaise, erythema and swelling was not resolved. It was unknown if the reporter considered the pain in arm, headache, general malaise, erythema and swelling to be related to Shingrix. It was unknown if the company considered the pain in arm, headache, general malaise, erythema and swelling to be related to Shingrix. Additional Information: GSK receipt date: 06-DEC-2025 The patient self-reported this case for herself. The batch number was not provided, and we are unable to contact the reporter.

Other medications

PANTOPRAZOLE; MULTIVITAMIN; GLUTATHIONE; PROBIOTICS NOS; PROGESTERONE; ESTRADIOL; TESTOSTERONE